Premium Article

Guarding and reinvigorating the senses to protect against dementia

Premium Article

Does raw milk offer meaningful health benefits?

Premium Article

Less protein, longer life?

Premium Article

A longevity playbook for building strength and muscle mass

Premium Article

The [almost] unbelievable relationship between “big pharma” and gray-market peptides

Premium Article

The end of Alzheimer’s?

Premium Article

GLP-1 medications beyond weight loss: how far could their benefits extend?

Premium Article

Should you choose organic food?

Premium Article

Lung cancer screening in never-smokers: the data

Premium Article

Growth hormone for musculoskeletal system repair

Premium Article

Reducing cardiovascular risk: a playbook for lipid-lowering pharmacotherapy

Premium Article

Thinking in trade-offs: a necessary antidote to diet tribalism

Premium Article

Does lowering cholesterol harm the brain?

Premium Article

GLP-1 Drugs Fail to Slow Cognitive Decline in Alzheimer’s Disease

Premium Article

Navigating the complex relationship between statins, GLP-1, and glycemic control

Premium Article

Alcohol and healthspan: knowing the risks and how to mitigate them

Premium Article

Understanding and improving important cardiovascular metrics

Premium Article

Short- and long-term effects of caffeine on health and performance

Premium Article

Metformin as a potential longevity medication: where do we stand?

Premium Article

All things blood pressure: from measurement to management

Premium Article

Evaluating NAD and NAD precursors for health and longevity

Premium Article

What can we learn from “blue zones”?

Premium Article

Cold therapy: the facts, the myths, and the how-to

Premium Article

A guide to Zone 2 training